SEC Form 4 · accession 0001209191-15-008490
IMMUNOMEDICS INC · IMMU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cynthia L Goldenberg
Officer — President and CEO · Director · 10% Owner
Period of report
Jan 29, 2015
Accepted (ET)
Feb 2, 2015 · 9:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000722830
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 29, 2015 | A | 58,479 | $0.00 | A | 555,434 | D | |
| Common Stock | Jan 29, 2015 | F | 21,935 | $5.28 | D | 533,499 | D | |
| Common StockF1,F3 | Jan 29, 2015 | A | 58,480 | $0.00 | A | 5,325,880 | I | See Footnote |
| Common StockF3 | Jan 29, 2015 | F | 21,963 | $5.28 | D | 5,303,917 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Such Performance Units represent the settlement of common stock underlying Performance Units that have vested in accordance with the terms of the Performance-Based Restricted Stock Unit Issuance Agreement.
- F2Includes a total of 190,000 shares held as joint tenants by the reporting person and her spouse.
- F3Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer, of which the reporting person is an officer. The reporting person disclaims beneficial ownership of these shares except to the extent of her pecuniary interests therein.